NASDAQ Careers: Find a Job Now
Web NASDAQ.com
Search
Save my stocks for next time

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

ACET: Stock Quote & Summary Data

$ 5.24 0.05 0.96%
Nov. 20, 2009 Market Closed
Update Quotes: . Updates every 7 Seconds.
Aceto Corporation
ACET | Aceto Corporation | Common Stock | Market : NASDAQ-GS

Last Sale
Change Net / %
Best Bid / Ask
1y Target Est: N/A
Today's High / Low  / 
Share Volume
50 Day Avg. Daily Volume 164,901
Previous Close $ 5.19
52 Wk High / Low $ 11.70 / $ 4.86
Shares Outstanding 24,779,000
Market Value $ 129,841,960
Annualized Dividend $ 0.20
Ex Dividend Date Jun. 11, 2009
Dividend Payment Date Jun. 26, 2009
Current Yield 3.85 %
Beta 1.34
NASDAQ Official Open Price: $ 5.18
Date of NASDAQ Official Open Price: Nov. 20, 2009
NASDAQ Official Close Price: $ 5.24
Date of NASDAQ Official Close Price: Nov. 20, 2009

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

Have a Question About ACET?

Ask your question about about Aceto Corporation (ACET) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!

Hot Topics in NASDAQ Answers

The most popular questions & answers in the
NASDAQ Answers Community:


 Company Description (as filed with the SEC)

Aceto Corporation, together with its consolidated subsidiaries, are referred to herein collectively as "Aceto", "Company", "we", "us", and "our" unless the content indicates otherwise. Aceto was incorporated in 1947 in the State of New York. We are a global leader in the sourcing, regulatory support, marketing and distribution of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and crop protection products. Our business is organized along product lines into three principal segments: Health Sciences, Chemicals & Colorants and Crop Protection. The Health Sciences segment is our largest segment in terms of both sales and gross profits. Products that fall within this segment include active pharmaceutical ingredients (API's), pharmaceutical intermediates, nutritionals and biopharmaceuticals. In fiscal 2007, we entered the market for finished dosage form generic drugs when we received orders for our first Aceto branded product, Isoflurane.  ... More ...  

Get ETF News, Commentary, Tools & more...

Visit the new NASDAQ.com ETFs hub Now

 Company News for ACET

Aceto Q1 Profit Dips - Quick Facts
- RTT News  11/06/2009 7:02AM
Aceto Announces Fiscal 2010 First Quarter Results of Operations
- GlobeNewswire  11/06/2009 6:55AM
Aceto Corporation Schedules Fiscal 2010 First Quarter Financial Results News Release and Conference Call
- GlobeNewswire  10/23/2009 6:55AM
Aceto Corp. Chairman And CEO Leonard Schwartz To Resign - Quick Facts
- RTT News  10/21/2009 10:23AM
Aceto Announces Management Realignment
- GlobeNewswire  10/21/2009 10:15AM
Airgas -- The Mad Money Post Game
- TheStreet  09/15/2009 12:32PM
Aceto Q4 09 Earnings Conference Call At 10:00 AM
- RTT News  09/11/2009 9:14AM